Aldeyra Therapeutics (ALDX) COO Young Resigns

September 2, 2016 7:03 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Aldeyra Therapeutics (NASDAQ: ALDX) disclosed the following in a U.S. SEC filing on Friday:

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On August 30, 2016, Aldeyra Therapeutics, Inc. (“Aldeyra”) and Scott L. Young agreed that Mr. Young would step down from his position as Chief Operating Officer of Aldeyra effective August 30, 2016.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Management Changes

Add Your Comment